EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of RACK1‐Mediated NLRP3 Oligomerization (Active Conformation) Ameliorates Acute Respiratory Distress Syndrome

Jian Cui, Meng Yang, Chengli Yu, Haidong Zhang, Yuan Gong, Yang Hu, Yue Wang, Qingxin Yuan, An Pan, Jiepin Li, Yaowen Hu, Zecheng Jin und 6 weitere

Advanced Science · 2025-07 · 12 (27)

DOI: 10.1002/advs.202411355 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 11.05.2025. Verfasst von Jian Cui und 17 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory for Functional Substance of Chinese Medicine, Stake Key Laboratory Cultivation Base for TCM Quality and Efficacy, School of Ph…. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Receptors for Activated C Kinase, Inflammasomes, Respiratory Distress Syndrome. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Industrial and Research Program of Jiangsu Provincial "333 Talent", National Natural Science Foundation of China from Nanjing University of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aberrant activation of the NACHT, LRR, and PYD domain‐containing protein 3 (NLRP3) inflammasome contributes to the pathogenesis of fatal and perplexing pulmonary diseases. Although pharmacological inhibition of the NLRP3 inflammasome brings potent therapeutic effects in clinical trials and preclinical models, the molecular chaperones and transition governing its transformation from an auto‐suppressed state to an active oligomer remain controversial. Here, this work shows that sesquiterpene bigelovin inhibited NLRP3 inflammasome activation and downstream pro‐inflammatory cytokines release via canonical, noncanonical, and alternative pathways at nanomolar ranges. Chemoproteomic target identification discloses that bigelovin covalently bound to Cys168 of RACK1, disrupting the interaction between RACK1 and NLRP3 monomer and thereby suppressing NLRP3 inflammasome oligomerization in vitro and in vivo. Bigelovin treatment significantly alleviates the severity of NLRP3‐related pulmonary disorders in murine models, such as LPS‐induced ARDS and silicosis. These results consolidated the intricate role of RACK1 in transiting the NLRP3 state and provided a new anti‐inflammatory lead and therapy for NLRP3‐driven diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinReceptors for Activated C KinaseInflammasomesRespiratory Distress SyndromeAnimalsMiceHumansDisease Models, AnimalMice, Inbred C57BLMaleNeoplasm Proteins

Stichwörter der Autor:innen

ARDSNLRP3 inflammasomeRACK1bigelovin

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinReceptors for Activated C KinaseInflammasomesRACK1 protein, humanRACK1 protein, mouseNeoplasm Proteins

Autor:innen und Institutionen

  • Jiangsu Key Laboratory for Functional Substance of Chinese Medicine, Stake Key Laboratory Cultivation Base for TCM Quality and Efficacy, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, 210029, China.
  • China Joint Graduate School of Traditional Chinese Medicine, Suzhou, Jiangsu, 215105, China.

ORCID-Profile: Yinan Zhang

Förderung

  • National Natural Science Foundation of China
  • Key Industrial and Research Program of Jiangsu Provincial "333 Talent"
  • National Natural Science Foundation of China from Nanjing University of Chinese Medicine
  • Postgraduate Research & Practice Innovation Program of Jiangsu Province
  • Chinese Medicine Leading Talent Project of Jiangsu Province
  • Open Project of Chinese Materia Medica First-Class Discipline of Nanjing University of Chinese Medicine
  • Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences and Peking Union Medical College

Zitieren

APA

Cui, J., Yang, M., Yu, C., Zhang, H., Gong, Y., Hu, Y., Wang, Y., Yuan, Q., Pan, A., Li, J., Hu, Y., Jin, Z., Peng, X., Wu, A., Wang, J., Wang, Q., Zhang, Y., & Hu, L. (2025). Inhibition of RACK1‐Mediated NLRP3 Oligomerization (Active Conformation) Ameliorates Acute Respiratory Distress Syndrome. Advanced Science, 12(27). https://doi.org/10.1002/advs.202411355

Vancouver

Cui J, Yang M, Yu C, Zhang H, Gong Y, Hu Y, et al. Inhibition of RACK1‐Mediated NLRP3 Oligomerization (Active Conformation) Ameliorates Acute Respiratory Distress Syndrome. Advanced Science. 2025;12(27). doi:10.1002/advs.202411355

BibTeX
@article{Cui2025,
  author = {Cui, Jian and Yang, Meng and Yu, Chengli and Zhang, Haidong and Gong, Yuan and Hu, Yang and Wang, Yue and Yuan, Qingxin and Pan, An and Li, Jiepin and Hu, Yaowen and Jin, Zecheng and Peng, Xuemei and Wu, Anyuan and Wang, Junwei and Wang, Qian and Zhang, Yinan and Hu, Lihong},
  title = {Inhibition of RACK1‐Mediated NLRP3 Oligomerization (Active Conformation) Ameliorates Acute Respiratory Distress Syndrome},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {27},
  doi = {10.1002/advs.202411355}
}
Kostenlos starten →